Log in
Enquire now
Nivien Therapeutics

Nivien Therapeutics

Nivien Therapeutics is a preclinical cancer therapies startup. Nivien is developing dual IO-chemo enhancers for cancers.

OverviewStructured DataIssuesContributors
Is a
Company
Company
Organization
Organization
Accelerator
IndieBio
IndieBio
B2X
B2B
B2B
0
CEO
Nathaniel Brooks Horwitz
Nathaniel Brooks Horwitz
0
CFO
‌
Nikita Shah
0
Company Operating Status
Active
Country
United States
United States
0
Crunchbase URL
crunchbase.com/organiz...apeutics
Email Address
nathaniel@generalbiotechnologies.com
0
nikita@generalbiotechnologies.com
0
Facebook URL
@nivientherapeutics
Founded Date
2016
Founder
‌
Nikita Shah
0
Nathaniel Brooks Horwitz
Nathaniel Brooks Horwitz
0
Full Address
125 Western Ave Bridge, Boston, Massachusetts 02134, US
0
479 Jessie Street, San Francisco California, 94103
0
Headquarters
San Francisco
San Francisco
Accelerator Batch
‌
IndieBio Class Six
Industry
Technology
Technology
‌
Therapeutic effect
Pharmaceutical industry
Pharmaceutical industry
Healthcare
Healthcare
Biopharmaceutical
Biopharmaceutical
Cancer
Cancer
Biology
Biology
Biotechnology
Biotechnology
Investors
SOSV
SOSV
LinkedIn URL
@company/nivien-therapeutics
Location
San Francisco
San Francisco
Boston
Boston
0
Number of Employees (Ranges)
1 – 10
0
Place of Incorporation
United States
United States
Public/Private
Private
0
Twitter URL
@nivientx
Official Website
nivientherapeutics.com

Find more companies like Nivien Therapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.